Elena Ridloff - Jun 16, 2021 Form 4/A - Amendment Insider Report for Kymera Therapeutics, Inc. (KYMR)

Role
Director
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
Stock symbol
KYMR
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/15/2022, 04:15 PM
Date Of Original Report
Jun 17, 2021
Previous filing
Apr 15, 2022
Next filing
Jun 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KYMR Stock Option (Right to Buy) Award $0 +10.5K $0.00 10.5K Jun 16, 2021 Common Stock 10.5K $49.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders.

Remarks:

This Amended Form 4 restates the original Form 4 in its entirety.